Journal of Commercial Biotechnology — January 2010 issue now available

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 1


Time for a new business model?PDF
Yali Friedman


Why data exclusivity is the new patent protectionPDF
Peter J Pitts
Follow-on biologic drug competition – No need for new marketing exclusivitiesPDF
Michael S Wroblewski, Elizabeth A Jex


Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumbPDF
Nigel Borshell, Adrian Dawkes
Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firmsPDF
Mark J Ahn, Michael Meeks, Sally Davenport, Rebecca Bednarek
Intellectual property landscape and patenting opportunity in biofuelsPDF
Ramasamy Mannan
Challenges and opportunities in the licensing of renewable technologiesPDF
Meredith Lloyd-Evans, Mike Gilbert, Ilian P Iliev
Ethiopia: Biotechnology for developmentPDF
Desta Berhe Sbhatu
Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economyPDF
Olivia Harvey

Legal and Regulatory Updates

Using IP audits to optimize IP assetsPDF
James G Cullem

Book Reviews

Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care servicesPDF
Frank LaSaracina
Book Review: Aging, Biotechnology, and the FuturePDF
Harley King

   No Comments yet

    Do NOT follow this link or you will be banned from the site!
    Get email updates

    Get new actionable insights and updates from BiotechBlog